Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials. (Q41197212)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786797%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

meta-analysis

0 references

title

Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786797%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786797%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Maria Pia Sormani

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786797%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

I Schiavetti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786797%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

F Gallo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786797%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

19 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786797%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neurology

3 March 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786797%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786797%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786797%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

960-966

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25786797%20AND%20SRC:MED&resulttype=core&format=json

Natural history of multiple sclerosis: long-term prognostic factors

3 March 2020

cites work

1 reference

Natural history of multiple sclerosis: early prognostic factors.

21 January 2018

1 reference

Determinants of interferon β efficacy in patients with multiple sclerosis

21 January 2018

1 reference

Defining and scoring response to IFN-β in multiple sclerosis.

21 January 2018

1 reference

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis

21 January 2018

1 reference

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study

21 January 2018

1 reference

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.

21 January 2018

1 reference

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

21 January 2018

1 reference

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.

21 January 2018

1 reference

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.

21 January 2018

1 reference

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis

21 January 2018

1 reference

Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes

21 January 2018

1 reference

Age and disability accumulation in multiple sclerosis

21 January 2018

1 reference